FDA Inspection 1088267 — WES Pharma Inc.
The FDA completed an inspection of WES Pharma Inc. on April 19, 2019 in Westminster, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 19, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Westminster, MD (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)